Methods and devices for treating lesions
An method and apparatus are disclosed including an expandable body having a diameter suitable for insertion into a blood vessel and capable of being modified from a first diameter to a second larger diameter in response to an inflation pressure. The expandable body includes an outer wall having a plurality of delivery outlets extending from a working length of the outer wall. The delivery outlets coincide with regions of a lesion exposed between a framework implanted within the vessel when the expandable body is in an expanded state. A treatment agent is delivered from the delivery outlets to regions of the lesion exposed between the implantable framework.
1. An apparatus comprising:
an expandable body suitable for insertion into a blood vessel and capable of expanding from a first diameter to a second diameter in response to an inflation pressure, the expandable body comprising:
an outer wall having a working length,
a plurality of needles extending from the outer wall, each of the needles having a lumen in fluid communication with an aperture formed in the outer wall, and
a plurality of recesses extending through only a portion of the outer wall, the recesses dimensioned to hold a treatment agent;
a delivery cannula coupled to the expandable body, the delivery cannula in fluid communication with each aperture such that a fluid introduced through the delivery cannula to expand the expandable body from the first diameter to the second diameter is delivered through the needles; and
a stent having struts and openings between the struts, the stent overlying the outer wall such that the needles align with the openings and the recesses align with the struts,
wherein the first diameter comprises a collapsed configuration and the second diameter comprises an expanded configuration, wherein the expanded configuration advances the needles through the openings to place the needles in contact with portions of a lesion exposed through the openings and releases the treatment agent into the blood vessel.
2. The apparatus of claim 1 wherein the expandable body is a balloon.
3. The apparatus of claim 1 wherein the fluid comprises a treatment agent and the expandable body is coupled to a distal portion of the delivery cannula, the delivery cannula having a length dimension suitable to be positioned from a first externally accessible site of a patient to a position within the blood vessel by way of a percutaneous transluminal route.
4. The apparatus of claim 1 wherein the expandable body further comprises:
an inner wall wherein an outer reservoir is defined by the outer wall and the inner wall and a separate inner reservoir is defined by the inner wall.
5. The apparatus of claim 1 wherein the needles are flexible.
6. The apparatus of claim 1 wherein a membrane covers an opening of each recess, the membrane having a property to rupture in response to one of expansion of the outer wall or biological conditions within the blood vessel, and wherein the treatment agent is released from the recess in response to the membrane rupture.
7. A method comprising:
introducing an expandable body having a stent crimped thereon to a point within a vessel lumen coextensive with a lesion, the expandable body comprising:
an outer wall having a working length,
a plurality of needles extending from the outer wall, each of the needles having a lumen in fluid communication with an aperture formed in the outer wall, and
a plurality of recesses extending through only a portion of the outer wall, the recesses dimensioned to hold a treatment agent, and
the stent comprising struts and openings between the struts, wherein the needles align with the openings and the recesses align with the struts;
after introducing the expandable body, inflating the expandable body from a first diameter having a collapsed configuration to a second diameter having an expanded configuration, wherein the expanded configuration advances the needles through the openings to place the needles in contact with portions of a lesion exposed through the openings;
delivering a fluid used to inflate the expandable body from the first diameter to the second diameter from the needles to the lesion; and
releasing the treatment agent from the recesses into the blood vessel.
8. The method of claim 7 wherein the expandable body is a balloon.
9. The method of claim 7 further comprising:
a delivery cannula wherein the expandable body is coupled to a distal portion of the delivery cannula for administering the fluid therein, the delivery cannula having a length dimension suitable to be positioned from a first externally accessible site of a patient to a position within the blood vessel by way of a percutaneous transluminal route.
10. The method of claim 7 wherein the expandable body further comprises:
an inner wall wherein an outer reservoir is defined by the outer wall and the inner wall and a separate inner reservoir is defined by the inner wall.
11. The method of claim 7 wherein the needles are flexible.
12. The method of claim 7 wherein a membrane covers an opening of each recess, and further comprising rupturing the membrane in response to the inflating, and wherein the releasing is in response to the rupturing.
13. The method of claim 7 wherein the fluid comprises a combination of a local treatment agent and a regional treatment agent.
14. The method of claim 13 wherein the local treatment agent is selected from the group consisting of paclitaxel and everolimus.
15. The method of claim 13 wherein the regional treatment agent is ApoA1.
16. The method of claim 7 wherein the fluid is delivered as a mixture including a treatment agent and a contrast agent.
17. A kit comprising:
a delivery cannula having a dimension suitable for insertion into a blood vessel toward a lesion and an expandable body coupled thereto, the expandable body comprising an outer wall having a working length capable of expanding from a first diameter to a second diameter in response to an inflation pressure, a plurality of needles extending from the outer wall, each of the needles having a lumen in fluid communication with an aperture formed in the outer wall, the delivery cannula in fluid communication with the expandable body and the needles such that a fluid introduced through the delivery cannula to expand the expandable body from the first diameter to the second diameter is delivered through the needles to the lesion, and a plurality of recesses extending through only a portion of the outer wall, the recesses dimensioned to hold a treatment agent;
a stent overlying the outer wall, the stent having a first outer diameter suitable for insertion into the blood vessel and a second outer diameter to retain a perimeter similar to that of the blood vessel, the stent having struts and openings between the struts, wherein the needles align with the openings and the recesses align with the struts; and
a fluid for delivery to a treatment site,
wherein the first diameter comprises a collapsed configuration and the second diameter comprises an expanded configuration, wherein the expanded configuration advances the needles through the openings to place the needles in contact with portions of the lesion and releases the treatment agent into the blood vessel.
18. The kit of claim 17 wherein the expandable body is a balloon.
19. The kit of claim 17 wherein the expandable body further comprises an inner wall concentrically inward from the outer wall, wherein an outer reservoir is defined by the outer wall and the inner wall and a separate inner reservoir is defined by the inner wall.
20. The kit of claim 17 wherein the needles are flexible.
21. The kit of claim 17 wherein a membrane covers an opening of each recess, the membrane having a property to rupture in response to one of expansion of the outer wall or biological conditions within the blood vessel, and wherein the treatment agent is released from the recess in response to the membrane rupture.
22. The kit of claim 17 wherein the fluid comprises a combination of a local treatment agent and a regional treatment agent.
23. The kit of claim 22 wherein the local treatment agent is selected from the group consisting of paclitaxel and everolimus.
24. The kit of claim 22 wherein the regional treatment agent is ApoA1.
25. The kit of claim 17 wherein the fluid is delivered as a mixture including a treatment agent and a contrast agent.